SCHEMBL6907067

SCHEMBL6907067

CC(C)(C)c1cc(O)cc(C(O)O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.62
GABRB2 P47870 1/20 0.62
LMNA P02545 5/20 0.40
KMT2A Q03164 4/20 0.40
HIF1A Q16665 4/20 0.40
CYP2C9 P11712 4/20 0.40
TSHR P16473 3/20 0.40
CASP7 P55210 2/20 0.40
CYP3A4 P08684 2/20 0.40
ADRB2 P07550 2/20 0.40
TYR P14679 2/20 0.39
ALDH1A1 P00352 5/20 0.35
ALOX15 P16050 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 3/20 0.35
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5964957 0.86 GABRA1 (0.52) GABRA1GABRB2LMNAKMT2ACYP2C9
SCHEMBL14205566 0.86 GABRA1 (0.46) GABRA1GABRB2LMNAKMT2ACYP2C9
SCHEMBL5168628 0.83 GABRA1 (0.62) GABRA1GABRB2LMNAKMT2AHIF1A
SCHEMBL18268 0.78 GABRA1 (1.00) GABRA1GABRB2LMNAKMT2AHIF1A
SCHEMBL123887 0.78 GABRA1 (0.88) GABRA1GABRB2LMNAKMT2AHIF1A
SCHEMBL682802 0.76 GABRA1 (0.54) GABRA1GABRB2LMNAKMT2AHIF1A
SCHEMBL14973413 0.76 GABRA1 (0.94) GABRA1GABRB2LMNAKMT2AHIF1A
SCHEMBL30897309 0.76 GABRA1 (0.94) GABRA1GABRB2LMNAKMT2AHIF1A
Hydrochloric Acid SCHEMBL7075850 0.76 GABRA1 (0.94) GABRA1GABRB2LMNAKMT2AHIF1A
SCHEMBL29444798 0.76 GABRA1 (0.94) GABRA1GABRB2LMNAKMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040048200-A1 Method for forming fine pattern on substrate by using resist pattern, and resist surface treatment agent RENESAS TECHNOLOGY CORP. (JP) 2004-03-11 US disclosed
US-5441983-A Herpes simplex virus, human immunodeficiency virus GENELABS INCORPORATED (US) 1995-08-15 US disclosed
US-5409959-A Administering sulfonate-substituted calixarene compound to inhibit thrombus formation GENELABS INCORPORATED (US) 1995-04-25 US disclosed
WO-1994003165-A1 ANTITHROMBOTIC TREATMENT WITH CALIX(N)ARENE COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 1994-02-17 WO disclosed
WO-1994003164-A1 INHIBITION AND TREATMENT OF INFECTION BY ENVELOPED VIRUS WITH CALIX(N) ARENE COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 1994-02-17 WO disclosed